Client News

Rentschler Biopharma SE: Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK

Rentschler Biopharma SE: Rentschler Biopharma to build new cell and gene therapy capabilities in the UK

XPhyto adds Mescaline production to psychedelic medicine programs

MagForce AG: MagForce USA, Inc. Announces Completion of Patient Treatment in Stage 2a of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

Secarna Pharmaceuticals: Secarna Pharmaceuticals appoints Alexander Gebauer, MD, PhD as CEO and Managing Director

Imcyse SA: Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid Arthritis

Imcyse SA: Imcyse Announces Start of Phase 1b/2a IMPACT Study in Patients with Recent Onset Type 1 Diabetes

XPhyto announces psychedelic pharmaceutical production agreement

CENTOGENE GmbH: CENTOGENE eröffnet Walk-In-Corona-Testzentrum am Flughafen Köln / Bonn

CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP® Technology in anti-tumor cell therapies